Mette Kolpen1, Kasper Nørskov Kragh2, Thomas Bjarnsholt1, Laura Line3, Christine Rønne Hansen4, Christina Schjellerup Dalbøge3, Nana Hansen5, Michael Kühl6, Niels Høiby1, Peter Østrup Jensen7. 1. Department of Clinical Microbiology, Rigshospitalet, 2100 Copenhagen, Denmark; Department of International Health, Immunology and Microbiology, Faculty of Health Sciences University of Copenhagen, 2200 Copenhagen, Denmark. 2. Department of International Health, Immunology and Microbiology, Faculty of Health Sciences University of Copenhagen, 2200 Copenhagen, Denmark. 3. Department of Clinical Microbiology, Rigshospitalet, 2100 Copenhagen, Denmark. 4. Department of Paediatrics, Copenhagen CF Centre, Rigshospitalet, 2100 Copenhagen, Denmark. 5. Department of Veterinary Disease Biology, Veterinary Clinical Microbiology, University of Copenhagen, 1870 Frederiksberg, Denmark. 6. Marine Biological Section, Department of Biology, University of Copenhagen, 3000 Helsingør, Denmark; Plant Functional Biology and Climate Change Cluster, University of Technology, Sydney, Australia; Singapore Centre on Environmental Life Sciences Engineering, Nanyang Technological University, Singapore. 7. Department of Clinical Microbiology, Rigshospitalet, 2100 Copenhagen, Denmark. Electronic address: Peter.Oestrup.Jensen@regionh.dk.
Abstract
OBJECTIVE: Chronic Pseudomonas aeruginosa lung infection is the most severe complication for cystic fibrosis (CF) patients. Infected endobronchial mucus of CF patients contains anaerobic zones mainly due to the respiratory burst of polymorphonuclear leukocytes. We have recently demonstrated ongoing denitrification in sputum from patients infected with P. aeruginosa. Therefore we aimed to investigate, whether the pathogenicity of several known CF pathogens is correlated to their ability to perform denitrification. METHODS: We measured denitrification with N(2)O microsensors in concert with anaerobic growth measurements by absorbance changes and colony counting in isolates from 32 CF patients chronically infected with the highly pathogenic bacteria P. aeruginosa, Achromobacter xylosoxidans, Burkholderia multivorans or the less pathogenic bacterium Stenotrophomonas maltophilia. Consumption of NO(3)(-) and NO(2)(-) was estimated by the Griess Assay. All isolates were assayed during 2 days of incubation in anaerobic LB broth with NO(3)(-) or NO(2)(-). PNA FISH staining of 16S rRNA was used to estimate the amount of ribosomes per bacterial cells and thereby the in situ growth rate of S. maltophilia in sputum. RESULTS: Supplemental NO(3)(-) caused increased production of N(2)O by P. aeruginosa, A. xylosoxidans and B. multivorans and increased growth for all pathogens. Growth was, however, lowest for S. maltophilia. NO(3)(-) was metabolized by all pathogens, but only P. aeruginosa was able to remove NO(2)(-). S. maltophilia had limited growth in sputum as seen by the weak PNA FISH staining. CONCLUSIONS: All four pathogens were able to grow anaerobically by NO(3)(-) reduction. Denitrification as demonstrated by N(2)O production was, however, not found in S. maltophilia isolates. The ability to perform denitrification may contribute to the pathogenicity of the infectious isolates since complete denitrification promotes faster anaerobic growth. The inability of S. maltophilia to proliferate by denitrification and therefore grow in the anaerobic CF sputum may explain its low pathogenicity in CF patients.
OBJECTIVE: Chronic Pseudomonas aeruginosa lung infection is the most severe complication for cystic fibrosis (CF) patients. Infected endobronchial mucus of CFpatients contains anaerobic zones mainly due to the respiratory burst of polymorphonuclear leukocytes. We have recently demonstrated ongoing denitrification in sputum from patients infected with P. aeruginosa. Therefore we aimed to investigate, whether the pathogenicity of several known CF pathogens is correlated to their ability to perform denitrification. METHODS: We measured denitrification with N(2)O microsensors in concert with anaerobic growth measurements by absorbance changes and colony counting in isolates from 32 CFpatients chronically infected with the highly pathogenic bacteria P. aeruginosa, Achromobacter xylosoxidans, Burkholderia multivorans or the less pathogenic bacterium Stenotrophomonas maltophilia. Consumption of NO(3)(-) and NO(2)(-) was estimated by the Griess Assay. All isolates were assayed during 2 days of incubation in anaerobic LB broth with NO(3)(-) or NO(2)(-). PNA FISH staining of 16S rRNA was used to estimate the amount of ribosomes per bacterial cells and thereby the in situ growth rate of S. maltophilia in sputum. RESULTS: Supplemental NO(3)(-) caused increased production of N(2)O by P. aeruginosa, A. xylosoxidans and B. multivorans and increased growth for all pathogens. Growth was, however, lowest for S. maltophilia. NO(3)(-) was metabolized by all pathogens, but only P. aeruginosa was able to remove NO(2)(-). S. maltophilia had limited growth in sputum as seen by the weak PNA FISH staining. CONCLUSIONS: All four pathogens were able to grow anaerobically by NO(3)(-) reduction. Denitrification as demonstrated by N(2)O production was, however, not found in S. maltophilia isolates. The ability to perform denitrification may contribute to the pathogenicity of the infectious isolates since complete denitrification promotes faster anaerobic growth. The inability of S. maltophilia to proliferate by denitrification and therefore grow in the anaerobic CF sputum may explain its low pathogenicity in CFpatients.
Authors: Sebastian H Kopf; Alex L Sessions; Elise S Cowley; Carmen Reyes; Lindsey Van Sambeek; Yang Hu; Victoria J Orphan; Roberta Kato; Dianne K Newman Journal: Proc Natl Acad Sci U S A Date: 2015-12-29 Impact factor: 11.205
Authors: Lici A Schurig-Briccio; Paola K Parraga Solorzano; Andrea M Lencina; Jana N Radin; Grischa Y Chen; John-Demian Sauer; Thomas E Kehl-Fie; Robert B Gennis Journal: EMBO Rep Date: 2020-03-23 Impact factor: 8.807
Authors: Cajetan Neubauer; Ajay S Kasi; Nora Grahl; Alex L Sessions; Sebastian H Kopf; Roberta Kato; Deborah A Hogan; Dianne K Newman Journal: J Bacteriol Date: 2018-11-26 Impact factor: 3.490
Authors: Thomas Bjarnsholt; Marvin Whiteley; Kendra P Rumbaugh; Philip S Stewart; Peter Ø Jensen; Niels Frimodt-Møller Journal: Lancet Infect Dis Date: 2021-09-07 Impact factor: 71.421